Enoxaparin clinically equivalent to UFH in the treatment of high-risk ACS

>Enoxaparin is an effective and safe alternative to unfractionated heparin (UFH) in the early and invasive management of high-risk patients with non-ST-elevation acute coronary syndromes (ACS), said Robert Califf, MD, at the 53rd Annual Scientific Session of the American College of Cardiology (ACC).

Related Content
© 2023 MJH Life Sciences

All rights reserved.